Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction

International Journal of Cardiology

Volumn 153, Issue 1, 2011, Pages 21-25

  Eitel, Ingo ^a   Desch, Steffen ^a   Schindler, Kathrin ^a   Fuernau, Georg ^a   Schuler, Gerhard ^a   Thiele, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Abciximab; Aborted myocardial infarction; Glycoprotein IIb IIIa inhibitor; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

ABCIXIMAB;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION SIZE; HUMAN; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 81055149626     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.027     Document Type: Article

References (27)

1. G. Montalescot, P. Barragan, and O. Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
2. G.W. Stone, C.L. Grines, and D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
3. F.J. Neumann, A. Kastrati, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction J Am Coll Cardiol 35 2000 915 921
4. S.J. Brener, L.A. Barr, and J.E. Burchenal Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators Circulation 98 1998 734 741
5. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885
6. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
7. J. Wohrle, T. Nusser, C. Mayer, M. Kochs, and V. Hombach Intracoronary application of abciximab in patients with ST-elevation myocardial infarction EuroIntervention 3 2008 465 469
8. E. Romagnoli, F. Burzotta, C. Trani, G.G. Biondi-Zoccai, F. Giannico, and F. Crea Rationale for intracoronary administration of abciximab J Thromb Thrombolysis 23 2007 57 63
9. H. Thiele, K. Schindler, and J. Friedenberger Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
10. J. Wohrle, O.C. Grebe, and T. Nusser Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty Circulation 107 2003 1840 1843
11. F. Bellandi, M. Maioli, M. Gallopin, A. Toso, and R.P. Dabizzi Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention Catheter Cardiovasc Interv 62 2004 186 192
12. E. Romagnoli, F. Burzotta, and C. Trani Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI Int J Cardiol 105 2005 250 255
13. F.W. Verheugt, B.J. Gersh, and P.W. Armstrong Aborted myocardial infarction: a new target for reperfusion therapy Eur Heart J 27 2006 901 904
14. I. Eitel, S. Desch, and M. Sareban Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty Am Heart J 158 2009 806 813
15. F. van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
16. K.P. Rentrop, M. Cohen, H. Blanke, and R.A. Phillips Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects J Am Coll Cardiol 5 1985 587 592
17. E.J. Lamfers, T.E. Hooghoudt, D.P. Hertzberger, A. Schut, P.W. Stolwijk, and F.W. Verheugt Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis Heart 89 2003 496 501
18. E.J. Lamfers, A. Schut, and D.P. Hertzberger Prehospital versus hospital fibrinolytic therapy using automated versus cardiologist electrocardiographic diagnosis of myocardial infarction: abortion of myocardial infarction and unjustified fibrinolytic therapy Am Heart J 147 2004 509 515
19. S.J. Marciniak Jr., M.A. Mascelli, and M.I. Furman An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates Thromb Haemost 87 2002 1020 1025
20. E.J. Lamfers, T.E. Hooghoudt, A. Uppelschoten, P.W. Stolwijk, and F.W. Verheugt Effect of prehospital thrombolysis on aborting acute myocardial infarction Am J Cardiol 84 1999 928
21. A.K. Hassan, J.W. Jukema, and A. van der Laarse Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment EuroIntervention 4 2009 662 668
22. R. Sciagra, G. Parodi, B. Sotgia, D. Antoniucci, and A. Pupi Determinants of final infarct size and incidence of aborted infarction in patients treated with primary coronary intervention and adjunctive abciximab therapy Nuklearmedizin 47 2008 56 61
23. T. Taher, Y. Fu, and G.S. Wagner Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy J Am Coll Cardiol 44 2004 38 43
24. V.C. Vasile, L. Babuin, and H.H. Ting Aborted myocardial infarction: is it real in the troponin era? Am Heart J 157 2009 636 641
25. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Eur Heart J 28 2007 2525 2538
26. I. Eitel, F. Behrendt, and K. Schindler Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging Eur Heart J 29 2008 2651 2659
27. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150